WebNov 24, 2024 · chinadrugtrials.org.cn identifier: CTR20160395. A phase III, randomized, double-blind, controlled trial of carboxyamidotriazole plus chemotherapy for the … http://lib.cpu.edu.cn/65/5c/c1197a91484/page.htm
Frontiers LZM008, a proposed tocilizumab biosimilar: …
WebNov 15, 2024 · A Phase II Open Label Study of Sacituzumab Govitecan in Patients With Solid Tumor. Actual Study Start Date : October 12, 2024. Estimated Primary Completion Date : December 2025. Estimated Study Completion Date : December 2025. Resource links provided by the National Library of Medicine. Drug Information available for: … WebJan 2, 2024 · 访问网址:http://www.chinadrugtrials.org.cn/eap/main数据库简介:国家食品药品监督管理总局药品审评中心(CenterforDrugEvaluation,CFDA)药物临床试验登记与信 … survivor panorama ihsan kimdir
A phase III, randomized, double-blind, controlled trial of ...
WebSep 25, 2024 · HSK7653-302 CTR20242424 ( Other Identifier: www.chinadrugtrials.org.cn ) First Posted: September 25, 2024 Key Record Dates: Last Update Posted: December 12, 2024 Last Verified: December 2024 Individual Participant Data (IPD) Sharing Statement: Plan to Share IPD: No WebFeb 15, 2024 · Breakthrough Therapy Designation in China is designed to expedite the development and review of investigational therapeutics for the treatment of serious and … WebFeb 15, 2024 · SHANGHAI and PRINCETON, N.J., Feb. 15, 2024 (GLOBE NEWSWIRE) -- LianBio (Nasdaq: LIAN), a biotechnology company dedicated to bringing innovative medicines to patients in China and other major Asian markets, today announced that the Center for Drug Evaluation (CDE) of the National Medical Products Administration … survivor panorama izle